Skip to Content Facebook Feature Image

Texas says an execution went as planned. A witness says screams showed 'tremendous distress'

News

Texas says an execution went as planned. A witness says screams showed 'tremendous distress'
News

News

Texas says an execution went as planned. A witness says screams showed 'tremendous distress'

2026-11-21 07:03 Last Updated At:07:10

A Texas official on Friday defended how the state carried out the execution of a 70-year-old man who loudly insisted he was in pain and pleaded, “Don't let me suffer like this,” during a lethal injection that followed a struggle to find a suitable vein.

Yet Reinaldo Dennes' spiritual adviser, who had his hand on Dennes' shoulder inside the death chamber in Huntsville, said he felt like he was holding a bucking bronco Thursday.

“Twice he said, 'It’s not working. It’s not working. It’s not going how it’s supposed to go. This isn’t right.' Those types of words kept coming,” said the Rev. Jeff Hood, a death penalty opponent.

Dennes was “clearly in tremendous distress,” said Hood, who called it torture.

It was the ninth execution this year in Texas, which has a long history of using the death penalty as punishment for murder. Executions across the U.S. have garnered more attention since Christa Pike survived two doses of pentobarbital in Tennessee in September. The drug didn't enter her bloodstream correctly.

Amanda Hernandez, a spokesperson for the Texas Department of Criminal Justice, said initial attempts to place two IV lines into Dennes' hands and arms were unsuccessful.

Dennes was strapped to the gurney at 6:04 p.m. Hernandez said an IV was successfully placed in the left side of his neck 16 minutes later at 6:20 p.m., followed by another line in his left foot at 6:38 p.m.

Witnesses, including Hood and an Associated Press reporter, were escorted into the death chamber before Dennes began his final statement at 6:52 p.m. Lethal drugs began flowing less than a minute later, Hernandez said.

Almost immediately, Dennes exclaimed: “The pain! Go! Go!” He uttered an expletive and implored “the father” to “take this pain.”

He subsequently shouted: “My right leg is killing me!” and described it as a cramp. After another profanity, he grunted, then said, “I don’t think this is normal. Take me, father. Don’t let me suffer like this. C’mon.”

The drugs were stopped at 7:07 p.m., and he was declared dead a minute later, slightly more than an hour after he was restrained in the death chamber, Hernandez said.

“We feel that all of our processes and procedures were followed and that it was carried out as planned,” she told the AP.

Hernandez said she didn’t know how many attempts were made to place IV lines.

“It’s not a race — it’s not how quickly can we get this done,” she said. “It’s something you want to do correctly. There is no normal time limit. It’s what it takes for it to be successfully done.”

In May, Tennessee called off the lethal injection of Tony Carruthers after failing for over an hour to establish an IV line. Idaho, in 2024, tried eight times to establish a line to execute Thomas Creech before stopping. Republican Gov. Brad Little subsequently signed a law making a firing squad the primary method of execution.

As for Dennes' claims of extreme pain, Hernandez said the state plans no additional inquiry. She said there were reasons to suspect he was exaggerating, adding that he complained even before the lethal drugs were given and grumbled about pain in a leg that didn't have an IV line.

Hernandez said “it makes you wonder” if the high-profile Pike case has influenced death row inmates to act out.

“They watch the news. He was aware of the other executions,” Hernandez said.

Dr. Paul Wax, executive director of the American College of Medical Toxicology, said he couldn’t think of any reason why an injection of pentobarbital into the left foot or left side of the neck would cause pain in the right leg.

Michael Graczyk, The AP reporter who attended the execution, said witnesses can't see when the drug starts to be administered. Dennes’ foot was covered by a sheet, and the IV in the left side of his neck wasn’t visible from their position.

It's not possible to definitively know what caused him to scream in pain. Hernandez said the lethal drugs had not passed their expiration date, though she didn't know the date.

Hood, the spiritual adviser, said assertions that Dennes was faking pain were “disgusting.”

“We have heard them say repeatedly since last night that this was not botched. That is absolutely, unbelievably absurd,” Hood said.

Dale Baich, an Arizona lawyer who has represented death row inmates and witnessed 17 U.S. executions, said the latest Texas lethal injection raises concerns.

“Calling a prisoner’s screams an act is not a medical finding. It is an accusation, and the state should be required to produce evidence to support it,” Baich said.

Associated Press reporter Kate Brumback in Atlanta contributed to this story.

This image provided by the Texas Department of Criminal Justice shows Reinaldo Dennes on April 14, 2026. (Texas Department of Criminal Justice via AP)

This image provided by the Texas Department of Criminal Justice shows Reinaldo Dennes on April 14, 2026. (Texas Department of Criminal Justice via AP)

JEFFERSON CITY, Mo. (AP) — Agrochemical maker Bayer will pay up to $7.25 billion over two decades to resolve thousands of claims from U.S. cancer patients asserting the company should have warned people that its popular weed killer Roundup could cause lymphoma, according to a settlement approved Friday by a Missouri judge.

The nationwide settlement applies both to Roundup users who already are ill and those who become diagnosed with non-Hodgkin lymphoma in future years. Participants could get an average of between $10,000 and $165,000, depending on how they used the product, how old they were when diagnosed and the severity of their illness.

For Germany-based Bayer, which denies that Roundup causes cancer, the settlement provides some financial certainty against mounting litigation costs that have led it to contemplate pulling the product from U.S. agricultural markets. Bayer already has changed the formula for its Roundup version sold to residential users.

Litigants also faced uncertainty. While the settlement was pending, the U.S. Supreme Court undercut one of the central arguments in the Roundup lawsuits. The high court ruled in June that Bayer cannot be sued in state courts on claims it failed to warn about cancer, because federal regulations don't require a cancer warning label and states are forbidden from imposing additional labeling requirements.

Though some attorneys for cancer patients contend the settlement payouts are too small, others argue the deal is better than getting nothing — which became a heightened likelihood after the Supreme Court ruling.

In a written judgment granting approval, St. Louis Circuit Judge Timothy Boyer said the average individual payouts are “fair and adequate” and the total dollar amount is “among the largest in the history of mass tort personal-injury class action settlements.” The approved settlement includes $600 million for attorneys' fees.

The judge said there was a risk Bayer would have filed for bankruptcy protection if the settlement had been rejected.

Bayer CEO Bill Anderson said in a statement that the court-approved settlement is “a decisive milestone in the company’s strategy to mitigate the risks of both pending and future Roundup litigation."

The decision could be appealed.

Missouri-based Monsanto debuted Roundup weed killer in 1974 with the chemical glyphosate as its active ingredient. The product quickly became one of the most widely used herbicides in agriculture. Roundup is designed to be used with genetically modified seeds that can resist the weed killer’s deadly effect, thus allowing farmers to produce more while conserving the soil by tilling it less.

The product also is commonly applied on lawns and gardens.

Bayer added Roundup to its portfolio when it acquired Monsanto in 2018. With it came a growing number of lawsuits alleging glyphosate causes non-Hodgkin lymphoma. But that remains in dispute. The World Health Organization’s International Agency for Research on Cancer classified the chemical as “probably carcinogenic” in 2015. The U.S. Environmental Protection Agency has determined that it’s not likely to cause cancer in humans when used as directed.

About 200,000 Roundup-related claims have been made against Bayer, many coming from people who used it on residential lawns and gardens. As a result, Bayer has removed glyphosate from its new versions of Roundup sold for residential markets.

The lawsuits have produced mixed results. Only a couple dozen cases have gone to jurors, some siding with Bayer and others with plaintiffs. In one case, a Georgia jury awarded plaintiffs $2.1 billion.

In the first Roundup verdict since the Supreme Court’s precedent-setting ruling, a Missouri jury in October sided with Bayer in a case alleging design defects, negligence and fraud. The verdict “should send a strong signal” that plaintiffs “will face significant challenges” pursuing Roundup-related cancer claims in the future, said Bill Dodero, Bayer’s U.S. general counsel and global litigation leader.

Bayer previously set aside $16 billion to cover legal costs related to Roundup cases. The new settlement, which is in addition to that, is designed to address most of the remaining lawsuits, as well as any additional cases brought in the coming years by people who were exposed to Roundup before the settlement was proposed in February.

“Today’s final approval order delivers guaranteed compensation to Roundup cancer victims who have waited more than a decade for justice," said Christopher A. Seeger, a court-appointed counsel for cancer patients in the case.

The settlement calls for Bayer to make annual payments into a special fund for up to 21 years, totaling as much as $7.25 billion. The amount of money paid out to individuals would vary. Agricultural, industrial or turf workers exposed at length to Roundup could receive an average of $165,000 if they were diagnosed with an aggressive form of the illness while younger than age 60. But anyone diagnosed at age 78 or older would get significantly less, with an average of $10,000.

Some attorneys have said the individual settlement amounts are too small and the terms too restrictive.

“This settlement is the scariest, worst future settlement that’s ever been contemplated,” attorney Gerson Smoger said during a September court hearing on whether the settlement was fair. He said it locked in future claimants for decades with no chance at punitive damages yet “kept the product that they were exposed to on the market, allowing the victims to continue to be exposed.”

The settlement was filed in St. Louis Circuit Court in Missouri, home to Bayer’s North America crop science division and the state where many of the lawsuits have been brought.

FILE - Containers of Roundup weedkiller are displayed on a store shelf in San Francisco, Feb. 24, 2019. (AP Photo/Haven Daley, File)

FILE - Containers of Roundup weedkiller are displayed on a store shelf in San Francisco, Feb. 24, 2019. (AP Photo/Haven Daley, File)

Recommended Articles